September 18, 2018 -- The American Society of Cataract and Refractive Surgery (ASCRS) announced today that it has convened a task force to review data from the COMPASS-XT study and associated research, and to develop a physician guidance document associated with the voluntary withdrawal of Alcon’s CyPass Micro-Stent.
You are here
Get involved and help shape the Annual Meeting program by submitting your instructional courses, scientific films, papers, posters and photos for the 2019 ASCRS•ASOA Annual Meeting, May 3-7 in San Diego, California. The deadline to submit courses, films, papers and posters is Wednesday, October 17. The deadline for photo submissions is Friday, January 11, 2019.
ASCRS-Led Coalition Releases Joint Guidelines for the Cleaning and Sterilization of Intraocular Surgical Instruments
Joint ASCRS, AAO, and OOSS Specialty-Specific Guidelines for Ophthalmic Instrument Cleaning and Sterilization
Medical Community Advocacy Prompts Anthem to Fully Rescind Payment Cuts for E&M Codes Billed with Modifier 25
Following reports that Anthem notified physicians in many states that it will begin reducing payments by 50% for evaluation and management (E&M) codes reported with a Current Procedural Terminology (CPT) modifier 25, the medical community intervened to prevent the cuts. In response, Anthem has announced that it will not move forward with its planned payment cuts. Last month, Anthem had originally responded to the medical community’s advocacy by lowering the proposed reduction to 25%.
In Major Legislative Win, Congress Passes Legislation that Includes a CR, Two-Year Budget Deal, IPAB Repeal, and ASCRS-Requested Technical Changes to MACRA Law
Early this morning, years of advocacy by ASCRS, the Alliance of Specialty Medicine, and the medical community have paid off in the form of IPAB repeal and much-needed technical changes to MACRA.
Issued on December 13, 2017, by the American Society of Cataract and Refractive Surgery
A recent alteration in the formulation of epinephrine from one of the more common sources of preservative-free epinephrine has contributed to a shortage or impending shortage of this product for ophthalmologists. In January 2017, PAR Pharmaceutical updated and began shipping the new formulation of epinephrine which in addition to containing 0.457 mg of sodium metabisulfite, will also contain 2.25 mg of tartaric acid per ml.